Skip to main content
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: Respir Med. 2014 Sep 28;108(11):1663–1669. doi: 10.1016/j.rmed.2014.09.013

Figure 1.

Figure 1

FVC and DLCO by group, spline at visit=0. Plotted values are estimates obtained from linear mixed models. Results apply to no prior smoking Caucasian male subjects of average age 54 years with active or progressive pulmonary sarcoidosis as the indication for IS therapy.